Anbio Biotechnology
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $4.2M |
| FY2022 | — | $12.5M | $7.1M |
| FY2023 | — | $14.8M | $9.7M |
| FY2024 | — | $17.2M | $11.8M |
| FY2025 | — | $30.2M | $7.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $4.2M |
| FY2022 | — | $12.5M | $7.1M |
| FY2023 | — | $14.8M | $9.7M |
| FY2024 | — | $17.2M | $11.8M |
| FY2025 | — | $30.2M | $7.8M |